Patch Kroger label

Patch Kroger

Patch Kroger Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

When using this product

  • Use only as directed
  • Avoid contact with eyes and mucous membranes
  • Do no apply to wounds or damaged skin
  • Do not bandage tightly or use a heating pad

Stop use and ask doctor if

  • Excessive redness or irritation is present
  • Condition worsens
  • Pain persists for more than 7 days
  • Symptoms clear up and occur again within a few days

If pregnant of breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Temporarily relieves minor aches and pains of muscles and joints due to

  • Arthritis          
  • Simple Backache            
  • Strains
  • Bursitis        
  • Tendonitis               
  • Bruises
  • Cramps

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Patch Kroger Manufacturers

  • Kroger
    Patch Kroger | Independence Pharmaceuticals, Llc
    No Recall

    Patch Kroger | Independence Pharmaceuticals, Llc

    Patch Kroger | Independence Pharmaceuticals, Llc

    Amphetamines should be administered at the lowest effective dosage and dosage should be individually adjusted. Late evening doses should be avoided because of the resulting insomnia.

    Narcolepsy: Usual dose is 5 mg to 60 mg per day in divided doses, depending on the individual patient response.

    Narcolepsy seldom occurs in children under 12 years of age; however, when it does, ProCentra®(dextroamphetamine sulfate) Oral Solution may be used. The suggested initial dose for patients aged 6 to 12 is 5 mg daily; daily dose may be raised in increments of 5 mg at weekly intervals until optimal response is obtained. In patients 12 years of age and older, start with 10 mg daily; daily dosage may be raised in increments of 10 mg at weekly intervals until optimal response is obtained. If bothersome adverse reactions appear (e.g., insomnia or anorexia), dosage should be reduced. Give first dose on awakening; additional doses (1 or 2) at intervals of 4 to 6 hours.

    Attention Deficit Disorder with Hyperactivity: Not recommended for pediatric patients under 3 years of age.

    In pediatric patients from 3 to 5 years of age, start with 2.5 mg daily; daily dosage may be raised in increments of 2.5 mg at weekly intervals until optimal response is obtained.

    In pediatric patients 6 years of age and older, start with 5 mg once or twice daily; daily dosage may be raised in increments of 5 mg at weekly intervals until optimal response is obtained. Only in rare cases will it be necessary to exceed a total of 40 mg per day.

    Give first dose on awakening; additional doses (1 or 2) at intervals of 4 to 6 hours.

    Where possible, drug administration should be interrupted occasionally to determine if there is a recurrence of behavioral symptoms sufficient to require continued therapy.